Patient Capital

Investment willing to be held long-term without demanding a quick return, often state-backed in China.

Patient capital is an economics concept for capital willing to be held long-term, without pursuing a quick exit or return. Since 2024 it has appeared frequently in Chinese policy documents; the decision from the Third Plenary Session of the 20th Party Central Committee called for “developing patient capital,” encouraging investment that's early, small, long-term, and directed at hard tech. Embodied-AI R&D cycles are long, and mass production and profitability are both still far off, so the typical five-to-seven-year exit window of ordinary venture capital often can't wait that long — making national- and local-level government guidance funds and state-owned platforms important sources of capital in this sector. It also has a side effect: regions competing to fund local projects can encourage homogenization and redundant construction.

ExampleThe National Artificial Intelligence Industry Investment Fund and various local government guidance funds have participated in the funding rounds of several humanoid-robot companies, moves the media often describes as state-backed patient capital entering the sector.

Also called

State-Backed Long-Term Investment

Related

National AI Industry Investment Fund · Funding Rounds & Valuation · Future Industries · New Quality Productive Forces · Homogenization / Redundant Construction · Embodied AI Bubble

Sources

Patient capital - Wikipedia